China Biopharmaceutical Buffers Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • A biopharmaceutical, also known as a biologic(al) medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources.

    This report offers an overview of the market trends, drivers, and barriers with respect to the China Biopharmaceutical Buffers market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Biopharmaceutical Buffers market. Detailed analysis of key players, along with key growth strategies adopted by Biopharmaceutical Buffers industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Nova Biomedicals

    • Becton, and Dickinson and Company

    • GE Healthcare

    • Thermo Fisher Scientific

    • Merck

    • Sartorius StedimBiotech

    • Danaher Corporation

    • Roche

    • GEA

    • Eppendorf

    • Lonza

    By Type:

    • Sterile Buffer

    • Non-sterile Buffer

    By End-User:

    • Recombinant Proteins

    • Monoclonal Antibodies

    • Antibiotics

    • Probiotics

    • Other

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Biopharmaceutical Buffers Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Biopharmaceutical Buffers Market Size and Growth Rate of Sterile Buffer from 2016 to 2027

    • 1.3.2 China Biopharmaceutical Buffers Market Size and Growth Rate of Non-sterile Buffer from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Biopharmaceutical Buffers Market Size and Growth Rate of Recombinant Proteins from 2016 to 2027

    • 1.4.2 China Biopharmaceutical Buffers Market Size and Growth Rate of Monoclonal Antibodies from 2016 to 2027

    • 1.4.3 China Biopharmaceutical Buffers Market Size and Growth Rate of Antibiotics from 2016 to 2027

    • 1.4.4 China Biopharmaceutical Buffers Market Size and Growth Rate of Probiotics from 2016 to 2027

    • 1.4.5 China Biopharmaceutical Buffers Market Size and Growth Rate of Other from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Biopharmaceutical Buffers Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Biopharmaceutical Buffers Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Biopharmaceutical Buffers Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Biopharmaceutical Buffers Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Biopharmaceutical Buffers Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Biopharmaceutical Buffers Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Biopharmaceutical Buffers Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Biopharmaceutical Buffers Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Biopharmaceutical Buffers by Major Types

    • 3.4.1 Market Size and Growth Rate of Sterile Buffer

    • 3.4.2 Market Size and Growth Rate of Non-sterile Buffer

    4 Segmentation of Biopharmaceutical Buffers Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Biopharmaceutical Buffers by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Biopharmaceutical Buffers in Recombinant Proteins

    • 4.4.2 Market Size and Growth Rate of Biopharmaceutical Buffers in Monoclonal Antibodies

    • 4.4.3 Market Size and Growth Rate of Biopharmaceutical Buffers in Antibiotics

    • 4.4.4 Market Size and Growth Rate of Biopharmaceutical Buffers in Probiotics

    • 4.4.5 Market Size and Growth Rate of Biopharmaceutical Buffers in Other

    5 Market Analysis by Regions

    • 5.1 China Biopharmaceutical Buffers Production Analysis by Regions

    • 5.2 China Biopharmaceutical Buffers Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Biopharmaceutical Buffers Landscape Analysis

    • 6.1 North China Biopharmaceutical Buffers Landscape Analysis by Major Types

    • 6.2 North China Biopharmaceutical Buffers Landscape Analysis by Major End-Users

    7 Central China Biopharmaceutical Buffers Landscape Analysis

    • 7.1 Central China Biopharmaceutical Buffers Landscape Analysis by Major Types

    • 7.2 Central China Biopharmaceutical Buffers Landscape Analysis by Major End-Users

    8 South China Biopharmaceutical Buffers Landscape Analysis

    • 8.1 South China Biopharmaceutical Buffers Landscape Analysis by Major Types

    • 8.2 South China Biopharmaceutical Buffers Landscape Analysis by Major End-Users

    9 East China Biopharmaceutical Buffers Landscape Analysis

    • 9.1 East China Biopharmaceutical Buffers Landscape Analysis by Major Types

    • 9.2 East China Biopharmaceutical Buffers Landscape Analysis by Major End-Users

    10 Northeast China Biopharmaceutical Buffers Landscape Analysis

    • 10.1 Northeast China Biopharmaceutical Buffers Landscape Analysis by Major Types

    • 10.2 Northeast China Biopharmaceutical Buffers Landscape Analysis by Major End-Users

    11 Southwest China Biopharmaceutical Buffers Landscape Analysis

    • 11.1 Southwest China Biopharmaceutical Buffers Landscape Analysis by Major Types

    • 11.2 Southwest China Biopharmaceutical Buffers Landscape Analysis by Major End-Users

    12 Northwest China Biopharmaceutical Buffers Landscape Analysis

    • 12.1 Northwest China Biopharmaceutical Buffers Landscape Analysis by Major Types

    • 12.2 Northwest China Biopharmaceutical Buffers Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Nova Biomedicals

      • 13.1.1 Nova Biomedicals Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Becton, and Dickinson and Company

      • 13.2.1 Becton, and Dickinson and Company Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 GE Healthcare

      • 13.3.1 GE Healthcare Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Thermo Fisher Scientific

      • 13.4.1 Thermo Fisher Scientific Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Merck

      • 13.5.1 Merck Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Sartorius StedimBiotech

      • 13.6.1 Sartorius StedimBiotech Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Danaher Corporation

      • 13.7.1 Danaher Corporation Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Roche

      • 13.8.1 Roche Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 GEA

      • 13.9.1 GEA Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Eppendorf

      • 13.10.1 Eppendorf Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    • 13.11 Lonza

      • 13.11.1 Lonza Company Profile and Recent Development

      • 13.11.2 Market Performance

      • 13.11.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Biopharmaceutical Buffers Market Size and Growth Rate of Sterile Buffer from 2016 to 2027

    • Figure China Biopharmaceutical Buffers Market Size and Growth Rate of Non-sterile Buffer from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Biopharmaceutical Buffers Market Size and Growth Rate of Recombinant Proteins from 2016 to 2027

    • Figure China Biopharmaceutical Buffers Market Size and Growth Rate of Monoclonal Antibodies from 2016 to 2027

    • Figure China Biopharmaceutical Buffers Market Size and Growth Rate of Antibiotics from 2016 to 2027

    • Figure China Biopharmaceutical Buffers Market Size and Growth Rate of Probiotics from 2016 to 2027

    • Figure China Biopharmaceutical Buffers Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Biopharmaceutical Buffers Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Biopharmaceutical Buffers Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Biopharmaceutical Buffers Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Biopharmaceutical Buffers Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Biopharmaceutical Buffers Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Biopharmaceutical Buffers Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Biopharmaceutical Buffers Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Biopharmaceutical Buffers Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Biopharmaceutical Buffers

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Biopharmaceutical Buffers by Different Types from 2016 to 2027

    • Table Consumption Share of Biopharmaceutical Buffers by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Sterile Buffer

    • Figure Market Size and Growth Rate of Non-sterile Buffer

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Biopharmaceutical Buffers by Different End-Users from 2016 to 2027

    • Table Consumption Share of Biopharmaceutical Buffers by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Recombinant Proteins

    • Figure Market Size and Growth Rate of Monoclonal Antibodies

    • Figure Market Size and Growth Rate of Antibiotics

    • Figure Market Size and Growth Rate of Probiotics

    • Figure Market Size and Growth Rate of Other

    • Table China Biopharmaceutical Buffers Production by Regions

    • Table China Biopharmaceutical Buffers Production Share by Regions

    • Figure China Biopharmaceutical Buffers Production Share by Regions in 2016

    • Figure China Biopharmaceutical Buffers Production Share by Regions in 2021

    • Figure China Biopharmaceutical Buffers Production Share by Regions in 2027

    • Table China Biopharmaceutical Buffers Consumption by Regions

    • Table China Biopharmaceutical Buffers Consumption Share by Regions

    • Figure China Biopharmaceutical Buffers Consumption Share by Regions in 2016

    • Figure China Biopharmaceutical Buffers Consumption Share by Regions in 2021

    • Figure China Biopharmaceutical Buffers Consumption Share by Regions in 2027

    • Table North China Biopharmaceutical Buffers Consumption by Types from 2016 to 2027

    • Table North China Biopharmaceutical Buffers Consumption Share by Types from 2016 to 2027

    • Figure North China Biopharmaceutical Buffers Consumption Share by Types in 2016

    • Figure North China Biopharmaceutical Buffers Consumption Share by Types in 2021

    • Figure North China Biopharmaceutical Buffers Consumption Share by Types in 2027

    • Table North China Biopharmaceutical Buffers Consumption by End-Users from 2016 to 2027

    • Table North China Biopharmaceutical Buffers Consumption Share by End-Users from 2016 to 2027

    • Figure North China Biopharmaceutical Buffers Consumption Share by End-Users in 2016

    • Figure North China Biopharmaceutical Buffers Consumption Share by End-Users in 2021

    • Figure North China Biopharmaceutical Buffers Consumption Share by End-Users in 2027

    • Table Central China Biopharmaceutical Buffers Consumption by Types from 2016 to 2027

    • Table Central China Biopharmaceutical Buffers Consumption Share by Types from 2016 to 2027

    • Figure Central China Biopharmaceutical Buffers Consumption Share by Types in 2016

    • Figure Central China Biopharmaceutical Buffers Consumption Share by Types in 2021

    • Figure Central China Biopharmaceutical Buffers Consumption Share by Types in 2027

    • Table Central China Biopharmaceutical Buffers Consumption by End-Users from 2016 to 2027

    • Table Central China Biopharmaceutical Buffers Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Biopharmaceutical Buffers Consumption Share by End-Users in 2016

    • Figure Central China Biopharmaceutical Buffers Consumption Share by End-Users in 2021

    • Figure Central China Biopharmaceutical Buffers Consumption Share by End-Users in 2027

    • Table South China Biopharmaceutical Buffers Consumption by Types from 2016 to 2027

    • Table South China Biopharmaceutical Buffers Consumption Share by Types from 2016 to 2027

    • Figure South China Biopharmaceutical Buffers Consumption Share by Types in 2016

    • Figure South China Biopharmaceutical Buffers Consumption Share by Types in 2021

    • Figure South China Biopharmaceutical Buffers Consumption Share by Types in 2027

    • Table South China Biopharmaceutical Buffers Consumption by End-Users from 2016 to 2027

    • Table South China Biopharmaceutical Buffers Consumption Share by End-Users from 2016 to 2027

    • Figure South China Biopharmaceutical Buffers Consumption Share by End-Users in 2016

    • Figure South China Biopharmaceutical Buffers Consumption Share by End-Users in 2021

    • Figure South China Biopharmaceutical Buffers Consumption Share by End-Users in 2027

    • Table East China Biopharmaceutical Buffers Consumption by Types from 2016 to 2027

    • Table East China Biopharmaceutical Buffers Consumption Share by Types from 2016 to 2027

    • Figure East China Biopharmaceutical Buffers Consumption Share by Types in 2016

    • Figure East China Biopharmaceutical Buffers Consumption Share by Types in 2021

    • Figure East China Biopharmaceutical Buffers Consumption Share by Types in 2027

    • Table East China Biopharmaceutical Buffers Consumption by End-Users from 2016 to 2027

    • Table East China Biopharmaceutical Buffers Consumption Share by End-Users from 2016 to 2027

    • Figure East China Biopharmaceutical Buffers Consumption Share by End-Users in 2016

    • Figure East China Biopharmaceutical Buffers Consumption Share by End-Users in 2021

    • Figure East China Biopharmaceutical Buffers Consumption Share by End-Users in 2027

    • Table Northeast China Biopharmaceutical Buffers Consumption by Types from 2016 to 2027

    • Table Northeast China Biopharmaceutical Buffers Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Biopharmaceutical Buffers Consumption Share by Types in 2016

    • Figure Northeast China Biopharmaceutical Buffers Consumption Share by Types in 2021

    • Figure Northeast China Biopharmaceutical Buffers Consumption Share by Types in 2027

    • Table Northeast China Biopharmaceutical Buffers Consumption by End-Users from 2016 to 2027

    • Table Northeast China Biopharmaceutical Buffers Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Biopharmaceutical Buffers Consumption Share by End-Users in 2016

    • Figure Northeast China Biopharmaceutical Buffers Consumption Share by End-Users in 2021

    • Figure Northeast China Biopharmaceutical Buffers Consumption Share by End-Users in 2027

    • Table Southwest China Biopharmaceutical Buffers Consumption by Types from 2016 to 2027

    • Table Southwest China Biopharmaceutical Buffers Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Biopharmaceutical Buffers Consumption Share by Types in 2016

    • Figure Southwest China Biopharmaceutical Buffers Consumption Share by Types in 2021

    • Figure Southwest China Biopharmaceutical Buffers Consumption Share by Types in 2027

    • Table Southwest China Biopharmaceutical Buffers Consumption by End-Users from 2016 to 2027

    • Table Southwest China Biopharmaceutical Buffers Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Biopharmaceutical Buffers Consumption Share by End-Users in 2016

    • Figure Southwest China Biopharmaceutical Buffers Consumption Share by End-Users in 2021

    • Figure Southwest China Biopharmaceutical Buffers Consumption Share by End-Users in 2027

    • Table Northwest China Biopharmaceutical Buffers Consumption by Types from 2016 to 2027

    • Table Northwest China Biopharmaceutical Buffers Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Biopharmaceutical Buffers Consumption Share by Types in 2016

    • Figure Northwest China Biopharmaceutical Buffers Consumption Share by Types in 2021

    • Figure Northwest China Biopharmaceutical Buffers Consumption Share by Types in 2027

    • Table Northwest China Biopharmaceutical Buffers Consumption by End-Users from 2016 to 2027

    • Table Northwest China Biopharmaceutical Buffers Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Biopharmaceutical Buffers Consumption Share by End-Users in 2016

    • Figure Northwest China Biopharmaceutical Buffers Consumption Share by End-Users in 2021

    • Figure Northwest China Biopharmaceutical Buffers Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Nova Biomedicals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nova Biomedicals

    • Figure Sales and Growth Rate Analysis of Nova Biomedicals

    • Figure Revenue and Market Share Analysis of Nova Biomedicals

    • Table Product and Service Introduction of Nova Biomedicals

    • Table Company Profile and Development Status of Becton, and Dickinson and Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Becton, and Dickinson and Company

    • Figure Sales and Growth Rate Analysis of Becton, and Dickinson and Company

    • Figure Revenue and Market Share Analysis of Becton, and Dickinson and Company

    • Table Product and Service Introduction of Becton, and Dickinson and Company

    • Table Company Profile and Development Status of GE Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GE Healthcare

    • Figure Sales and Growth Rate Analysis of GE Healthcare

    • Figure Revenue and Market Share Analysis of GE Healthcare

    • Table Product and Service Introduction of GE Healthcare

    • Table Company Profile and Development Status of Thermo Fisher Scientific

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Thermo Fisher Scientific

    • Figure Sales and Growth Rate Analysis of Thermo Fisher Scientific

    • Figure Revenue and Market Share Analysis of Thermo Fisher Scientific

    • Table Product and Service Introduction of Thermo Fisher Scientific

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Sartorius StedimBiotech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sartorius StedimBiotech

    • Figure Sales and Growth Rate Analysis of Sartorius StedimBiotech

    • Figure Revenue and Market Share Analysis of Sartorius StedimBiotech

    • Table Product and Service Introduction of Sartorius StedimBiotech

    • Table Company Profile and Development Status of Danaher Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Danaher Corporation

    • Figure Sales and Growth Rate Analysis of Danaher Corporation

    • Figure Revenue and Market Share Analysis of Danaher Corporation

    • Table Product and Service Introduction of Danaher Corporation

    • Table Company Profile and Development Status of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

    • Table Company Profile and Development Status of GEA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GEA

    • Figure Sales and Growth Rate Analysis of GEA

    • Figure Revenue and Market Share Analysis of GEA

    • Table Product and Service Introduction of GEA

    • Table Company Profile and Development Status of Eppendorf

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eppendorf

    • Figure Sales and Growth Rate Analysis of Eppendorf

    • Figure Revenue and Market Share Analysis of Eppendorf

    • Table Product and Service Introduction of Eppendorf

    • Table Company Profile and Development Status of Lonza

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lonza

    • Figure Sales and Growth Rate Analysis of Lonza

    • Figure Revenue and Market Share Analysis of Lonza

    • Table Product and Service Introduction of Lonza


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.